Read More Healthcare Industry News Lumos Diagnostics shares surge 155% on ASX after $317m U.S. FebriDx deal with PHASE Scientific Lumos Diagnostics surges 155% after securing a $487M U.S. FebriDx deal with PHASE Scientific. Find out what this means for investors in 2025. byPallavi MadhirajuJuly 16, 2025